Literature DB >> 28553929

Silencing of HIV-1 by AgoshRNA molecules.

E Herrera-Carrillo1, A Harwig1, B Berkhout1.   

Abstract

RNA interference (RNAi) is a sequence-specific gene silencing mechanism that is triggered by the expression of a short hairpin RNA (shRNA). shRNA molecules enter the RNAi pathway at the Dicer processing step. Recent studies indicated that the cellular microRNA miR-451 is not recognized by Dicer, but that it is processed instead by the Argonaute 2 (Ago2) protein. Subsequently, Dicer-independent shRNAs were described that rely on Ago2 for processing, as well as the subsequent silencing step. We called these AgoshRNA molecules because they depend on Ago2 both for maturation and activation. Processing of an AgoshRNA yields only a single active RNA strand, thus reducing the chance of adverse off-target effects induced by the passenger strand of regular shRNAs. In this study, we converted several anti-HIV-1 shRNAs into AgoshRNAs. Seven of the 21 designed AgoshRNAs were potent anti-HIV molecules, although their RNAi activity is generally somewhat reduced compared with the matching shRNAs. The AgoshRNA candidates revealed no cellular toxicity. This may relate to the absence of passenger strand expression, which was verified for these AgoshRNA candidates. Furthermore, we demonstrate that a toxic shRNA can be converted into a non-toxic AgoshRNA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28553929     DOI: 10.1038/gt.2017.44

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  59 in total

1.  Rational siRNA design for RNA interference.

Authors:  Angela Reynolds; Devin Leake; Queta Boese; Stephen Scaringe; William S Marshall; Anastasia Khvorova
Journal:  Nat Biotechnol       Date:  2004-02-01       Impact factor: 54.908

2.  Toward optimization of AgoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs.

Authors:  Elena Herrera-Carrillo; Alex Harwig; Ben Berkhout
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  Absence of DICER in monocytes and its regulation by HIV-1.

Authors:  William Coley; Rachel Van Duyne; Lawrence Carpio; Irene Guendel; Kylene Kehn-Hall; Sebastien Chevalier; Aarthi Narayanan; Truong Luu; Norman Lee; Zachary Klase; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

4.  Importance of translation and nonnucleolytic ago proteins for on-target RNA interference.

Authors:  Ligang Wu; Jihua Fan; Joel G Belasco
Journal:  Curr Biol       Date:  2008-09-09       Impact factor: 10.834

Review 5.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

6.  Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology.

Authors:  Jan M Ruijter; Helene H Thygesen; Onard J L M Schoneveld; Atze T Das; Ben Berkhout; Wouter H Lamers
Journal:  Retrovirology       Date:  2006-01-06       Impact factor: 4.602

7.  The influence of the 5΄-terminal nucleotide on AgoshRNA activity and biogenesis: importance of the polymerase III transcription initiation site.

Authors:  Elena Herrera-Carrillo; Zong-Liang Gao; Alex Harwig; Matthias T Heemskerk; Ben Berkhout
Journal:  Nucleic Acids Res       Date:  2017-04-20       Impact factor: 16.971

8.  Sequence features associated with microRNA strand selection in humans and flies.

Authors:  Hai Yang Hu; Zheng Yan; Ying Xu; Hao Hu; Corinna Menzel; Yan Hong Zhou; Wei Chen; Philipp Khaitovich
Journal:  BMC Genomics       Date:  2009-09-04       Impact factor: 3.969

9.  microRNAs associated with the different human Argonaute proteins.

Authors:  Anne Dueck; Christian Ziegler; Alexander Eichner; Eugene Berezikov; Gunter Meister
Journal:  Nucleic Acids Res       Date:  2012-07-25       Impact factor: 16.971

10.  Deep Sequence Analysis of AgoshRNA Processing Reveals 3' A Addition and Trimming.

Authors:  Alex Harwig; Elena Herrera-Carrillo; Aldo Jongejan; Antonius Hubertus van Kampen; Ben Berkhout
Journal:  Mol Ther Nucleic Acids       Date:  2015-07-14       Impact factor: 10.183

View more
  8 in total

Review 1.  Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.

Authors:  Elena Herrera-Carrillo; Ying Poi Liu; Ben Berkhout
Journal:  Hum Gene Ther Methods       Date:  2017-08       Impact factor: 2.396

Review 2.  RNA Interference Therapies for an HIV-1 Functional Cure.

Authors:  Robert J Scarborough; Anne Gatignol
Journal:  Viruses       Date:  2017-12-27       Impact factor: 5.048

3.  Influence of a 3' Terminal Ribozyme on AgoshRNA Biogenesis and Activity.

Authors:  Elena Herrera-Carrillo; Zongliang Gao; Ben Berkhout
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-08

4.  Gene knockdown in malaria parasites via non-canonical RNAi.

Authors:  Franziska Hentzschel; Vera Mitesser; Sabine Anne-Kristin Fraschka; Daria Krzikalla; Elena Herrera Carrillo; Ben Berkhout; Richárd Bártfai; Ann-Kristin Mueller; Dirk Grimm
Journal:  Nucleic Acids Res       Date:  2020-01-10       Impact factor: 16.971

5.  In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack.

Authors:  Mouraya Hussein; Zaria Andrade Dos Ramos; Ben Berkhout; Elena Herrera-Carrillo
Journal:  Viruses       Date:  2022-02-14       Impact factor: 5.048

Review 6.  Dicer-independent processing of small RNA duplexes: mechanistic insights and applications.

Authors:  Elena Herrera-Carrillo; Ben Berkhout
Journal:  Nucleic Acids Res       Date:  2017-10-13       Impact factor: 16.971

7.  Influence of the loop size and nucleotide composition on AgoshRNA biogenesis and activity.

Authors:  Elena Herrera-Carrillo; Alex Harwig; Ben Berkhout
Journal:  RNA Biol       Date:  2017-11-03       Impact factor: 4.652

8.  Short Hairpin RNAs for Strand-Specific Small Interfering RNA Production.

Authors:  Peike Sheng; Krystal A Flood; Mingyi Xie
Journal:  Front Bioeng Biotechnol       Date:  2020-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.